Loading...

Major Indexes

Financial Statements

GW Pharmaceuticals Plc

GW Pharmaceuticals Plc (GWPH)

$126.92
1.67 (+1.33%)

Income Statement

Download GWPH income statement Download GWPH income statement Download GWPH income statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011
Earnings Per Share Basic -------0.04--0.02
Net Profit Margin -------7.20--0.03
Earnings Per Share Diluted -------0.04--0.02
Revenue ------12.73-311.33
Weighted Average Shares Outstanding --------371.58
Gross Profit 28.2832.2826.0227.9825.928.914.11-284.13
Weighted Average Shares Outstanding (Diluted) ---177.52177.52236.65272.17-371.58
Sales, General and Administrative Expense ------33.19-259.88
Dividend per Share ---------
Operating Income 2.271.08-10.23-22.83-63.43-128.65-166.16--118.42
Gross Margin ------0.70-0.91
Earnings before Tax -------92.39--9.20
EBITDA Margin -0.100.06-0.34-0.60-1.92-6.83--0.35
Net Income -------91.70--9.02
EBIT Margin -------7.24--0.38
Net Income - Discounted ops ---------
Profit Margin -0.090.07-0.17-0.49-1.56-7.20--0.03
Preferred Dividends ---------
Free Cash Flow margin -------0.00--0.00
R&D Expenses ------104.38-142.68
Interest Expense 0.000.000.060.060.070.240.95-1.09
Earnings Before Tax Margin -------7.26--0.03
Consolidated Income -------91.70--9.02
EBIT 2.531.24-10.29-19.51-56.99-92.14-170.54--118.42
EBITDA -------86.99--109.19
Income Tax Expense -------0.69--0.18
Operating Expenses 26.0131.2036.2550.8189.35137.56170.27-402.56
Cost of Revenue ------3.82-27.20
Net Income Com -------91.70--9.02
Net Income - Non-Controlling int ---------

Balance Sheet Statement

Download GWPH balance shet statement Download GWPH balance sheet statement Download GWPH balance sheet statement
Year 2019 2018 2017 2016 2015 2014 2013 2012
Total current liabilities 11.5612.7217.3327.7745.5144.9166.22117.56
Other Liabilities 2.453.18-3.10-4.8139.9437.15--
Long-term debt -1.911.781.5410.866.351.4521.65
Cash and cash equivalents 29.3438.07164.49234.87487.51322.15591.50536.93
Total debt --2.001.911.655.173.0129.41
Cash and short-term investments 29.3438.07164.49234.87487.51322.15591.50536.93
Deferred revenue -12.5812.1012.719.998.04--
Inventories 3.544.664.784.765.535.6733.0385.53
Tax Liabilities ----0.370.882.380.44
Goodwill and Intangible Assets 5.215.215.215.466.786.96--
Deposit Liabilities --------
Tax assets -0.823.795.5313.0625.208.7218.12
Total non-current liabilities -10.1310.8217.5916.7119.7415.7738.65
Total current assets 35.2847.36176.38255.14526.74364.58646.62699.64
Total liabilities 21.6923.5434.9244.4871.2162.1081.99156.22
Payables 9.119.4420.3032.474.477.769.809.99
Other comprehensive income ------1,581.141,632.05
Short-term investments --------
Retained earnings (deficit) -65.03-68.97-81.46-123.45-231.56-461.87-828.94-837.96
Property, Plant & Equipment Net 2.435.4811.6428.7350.7163.1790.83127.77
Total non-current assets -7.6411.5817.1334.6148.66109.45182.61
Other Assets -----35.39--
Net Debt ------315.80-588.48-507.52
Investments --------
Total shareholders equity 21.2335.40158.58245.27518.89380.82674.08726.03
Total assets 42.9258.94193.50289.75590.10442.92756.07882.25
Long-term investments --------
Receivables 1.591.731.862.8730.261.374.1948.88
Short-term debt -0.100.130.111.10-1.567.76

Cash Flow Statement

Download GWPH cash flow statement Download GWPH cash flow statement Download GWPH cash flow statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011
Insurance (repayment) of debt ---------
Net Cash/Marketcap ------0.00--
Insurance (buybacks) of shares ---------
Depreciation & Amortization ------5.15-9.24
Dividend payments ---------
Operating Cash Flow 2.361.80-7.47-12.63-46.47-119.93-148.97--123.47
Acquisitions and disposals ---------
Free Cash Flow -1.470.48-9.71-19.87-64.38-132.84--165.96
Net cash flow / Change in cash -3.111.028.73126.4270.38128.15591.50-54.56
Effect of forex changes on cash --0.010.200.031.886.22-13.27-5.33
Financing Cash Flow 1.390.0718.25144.27128.42274.26-1.21-1.95
Investment purchases and sales ---------
Capital Expenditure -0.89-1.32-2.24-7.24-17.91-12.91-20.10-42.49
Stock-based compensation -0.801.010.621.242.4812.66-48.03
Investing Cash Flow ---------

Retained Earning Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012
Retained Earnings (Previous Year) --65-69-81-123-232-462-829
Net Income ------92--9
Stock Dividends -65-4-12-42-108-139-367-
Dividend Paid --------
Retained Earnings -65-69-81-123-232-462-829-838

PPE Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012
Gross PPE -251229516391
Annual Depreciation 451335353328-6
Capital Expenditure -1-2-7-18-13-20-42
Net PPE 251229516391128

Intangible and Goodwill Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012
Intangible and Goodwill (Previous Year) -555577-
New Purchases --------
Intangible and Goodwill 555577--

GW Pharmaceuticals Plc income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes GW Pharmaceuticals Plc FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.